The current state of clinical application of serum biomarkers for canine lymphoma.
Serum biomarkers of canine lymphoma activity for diagnosis, prognosis, and therapy monitoring have been of clinical interest for more than a decade. Tumor products, biochemical enzymes, cytokines, metabolic profiling, leakage enzymes, as well as serum proteins have been studied as biomarkers for ly...
Main Author: | Jeffrey N Bryan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fvets.2016.00087/full |
Similar Items
-
Feline thymidine kinase 1: molecular characterization and evaluation of its serum form as a diagnostic biomarker
by: Liya Wang, et al.
Published: (2021-09-01) -
Characterization of serum protein electrophoresis patterns and C-reactive protein in canine tick-borne diseases
by: Sariya Asawakarn, et al.
Published: (2021-08-01) -
Serum concentrations of Thymidine kinase 1 measured using a novel antibody-based assay in patients with Hodgkin Lymphoma
by: Johan Mattsson Ulfstedt, et al.
Published: (2021-08-01) -
Serum protein profiles and C-reactive protein in natural canine filariasis
by: Sariya Asawakarn, et al.
Published: (2021-04-01) -
Biomarker analysis and clinical relevance of TK1 on the cell membrane of Burkitt’s lymphoma and acute lymphoblastic leukemia
by: Weagel EG, et al.
Published: (2017-09-01)